PL3010940T3 - Nowe sposoby wytwarzania chemicznie zmodyfikowanych heparyn - Google Patents

Nowe sposoby wytwarzania chemicznie zmodyfikowanych heparyn

Info

Publication number: PL3010940T3
Authority: PL; Poland
Prior art keywords: chemically; production; new processes; modified heparins; heparins
Prior art date: 2013-06-19

Application number

PL14739914T

Other languages

English (en)

Inventor

Per-Olov Eriksson

Erik Yngve Holmer

Original Assignee

Dilafor Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-06-19

Filing date

2014-06-19

Publication date

2018-01-31

2014-06-19 Application filed by Dilafor Ab filed Critical Dilafor Ab

2018-01-31 Publication of PL3010940T3 publication Critical patent/PL3010940T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Polymers & Plastics (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Saccharide Compounds (AREA)

PL14739914T 2013-06-19 2014-06-19 Nowe sposoby wytwarzania chemicznie zmodyfikowanych heparyn PL3010940T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB1310928.5A GB2515315A (en)	2013-06-19	2013-06-19	New Processes
EP14739914.1A EP3010940B1 (en)	2013-06-19	2014-06-19	New processes for the production of chemically-modified heparins
PCT/GB2014/051878 WO2014202982A1 (en)	2013-06-19	2014-06-19	New processes for the production of chemically-modified heparins

Publications (1)

Publication Number	Publication Date
PL3010940T3 true PL3010940T3 (pl)	2018-01-31

Family

ID=48914809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14739914T PL3010940T3 (pl)	2013-06-19	2014-06-19	Nowe sposoby wytwarzania chemicznie zmodyfikowanych heparyn

Country Status (15)

Country	Link
US (1)	US10023659B2 (pl)
EP (1)	EP3010940B1 (pl)
JP (1)	JP6378328B2 (pl)
CN (1)	CN105324398B (pl)
CA (1)	CA2914256C (pl)
DK (1)	DK3010940T3 (pl)
ES (1)	ES2646337T3 (pl)
GB (1)	GB2515315A (pl)
HU (1)	HUE037037T2 (pl)
IL (1)	IL242888B (pl)
LT (1)	LT3010940T (pl)
PL (1)	PL3010940T3 (pl)
PT (1)	PT3010940T (pl)
TW (1)	TWI672146B (pl)
WO (1)	WO2014202982A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108424474B (zh) *	2017-02-15	2023-07-25	清华大学	去抗凝肝素衍生物及其用于炎症性肠病的治疗
CN115103679A (zh)	2020-02-17	2022-09-23	迪乐方有限责任公司	用于治疗先兆子痫的他福昔肝素
EP4272749A1 (en)	2022-05-03	2023-11-08	Dilafor AB	New medical use of tafoxiparin
JP2025514038A (ja)	2022-05-03	2025-05-02	ディラフォールアクチエボラグ	タフォキシパリンの新規な医学的使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2614026B1 (fr) *	1987-04-16	1992-04-17	Sanofi Sa	Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
FR2663639B1 (fr) *	1990-06-26	1994-03-18	Rhone Poulenc Sante	Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
SE9101155D0 (sv)	1991-04-18	1991-04-18	Kabi Pharmacia Ab	Novel heparin derivatives
GB2299998B (en) *	1995-03-31	1997-03-26	Hamilton Civic Hospitals Res	Compositions for inhibiting thrombogenesis
US5767269A (en)	1996-10-01	1998-06-16	Hamilton Civic Hospitals Research Development Inc.	Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
EP1033375A4 (en)	1997-11-20	2002-04-24	Ikuo Yamashina	MODIFICATION OF LOW MOLECULAR MASS HEPARIN AND REMEDY FOR SKIN Ulcer
DE69931038T2 (de)	1998-02-26	2006-11-23	Seikagaku Corp.	Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
JP4585072B2 (ja) *	2000-02-29	2010-11-24	扶桑薬品工業株式会社	ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
US20060040896A1 (en)	2004-08-18	2006-02-23	Paringenix, Inc.	Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US20070021378A1 (en)	2005-07-22	2007-01-25	The Regents Of The University Of California	Heparin compositions and selectin inhibition
JP2008120441A (ja) *	2006-11-15	2008-05-29	Maruichi Valve Co Ltd	エアゾール容器用噴射装置
CN100467493C (zh) *	2007-02-01	2009-03-11	高树华	一种低分子量肝素钙生产工艺
WO2009007224A1 (en) *	2007-07-10	2009-01-15	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Low molecular weight heparin derivatives having neuroprotective activity
US8592393B2 (en)	2007-11-02	2013-11-26	Momenta Pharmaceuticals, Inc.	Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
CA2703848C (en)	2007-11-02	2016-10-11	Momenta Pharmaceuticals, Inc.	Non-anticoagulant polysaccharide compositions
BR112014014454B1 (pt) *	2011-12-19	2021-03-09	Dilafor Ab	glicosaminoglicanos não anti-coagulativos compreendendo unidade de dissacarìdo repetida e seus usos médicos
WO2013095215A1 (en)	2011-12-19	2013-06-27	Dilaforette Ab	Low anticoagulant heparins
JP2018034714A (ja) *	2016-09-01	2018-03-08	日立金属株式会社	車両用ホイール

2013
- 2013-06-19 GB GB1310928.5A patent/GB2515315A/en not_active Withdrawn
2014
- 2014-06-18 TW TW103120997A patent/TWI672146B/zh active
- 2014-06-19 PT PT147399141T patent/PT3010940T/pt unknown
- 2014-06-19 HU HUE14739914A patent/HUE037037T2/hu unknown
- 2014-06-19 WO PCT/GB2014/051878 patent/WO2014202982A1/en not_active Ceased
- 2014-06-19 EP EP14739914.1A patent/EP3010940B1/en active Active
- 2014-06-19 ES ES14739914.1T patent/ES2646337T3/es active Active
- 2014-06-19 US US14/898,862 patent/US10023659B2/en active Active
- 2014-06-19 JP JP2016520743A patent/JP6378328B2/ja active Active
- 2014-06-19 LT LTEP14739914.1T patent/LT3010940T/lt unknown
- 2014-06-19 CA CA2914256A patent/CA2914256C/en active Active
- 2014-06-19 CN CN201480034904.4A patent/CN105324398B/zh active Active
- 2014-06-19 DK DK14739914.1T patent/DK3010940T3/en active
- 2014-06-19 PL PL14739914T patent/PL3010940T3/pl unknown
2015
- 2015-12-02 IL IL242888A patent/IL242888B/en active IP Right Grant

Also Published As

Publication number	Publication date
PT3010940T (pt)	2017-11-14
CA2914256A1 (en)	2014-12-24
HK1220475A1 (en)	2017-05-05
IL242888B (en)	2018-08-30
HUE037037T2 (hu)	2018-08-28
CA2914256C (en)	2021-03-02
US10023659B2 (en)	2018-07-17
ES2646337T3 (es)	2017-12-13
CN105324398B (zh)	2018-06-01
GB201310928D0 (en)	2013-07-31
EP3010940B1 (en)	2017-08-09
GB2515315A (en)	2014-12-24
WO2014202982A1 (en)	2014-12-24
EP3010940A1 (en)	2016-04-27
JP2016522302A (ja)	2016-07-28
CN105324398A (zh)	2016-02-10
DK3010940T3 (en)	2017-10-30
LT3010940T (lt)	2017-09-25
JP6378328B2 (ja)	2018-08-22
TWI672146B (zh)	2019-09-21
US20160137754A1 (en)	2016-05-19
TW201534309A (zh)	2015-09-16

Publication	Publication Date	Title
PL2981641T3 (pl)	2024-07-22	Sposób wytwarzania wyrobów kształtowanych z celulozy
GB2511914B (en)	2015-09-23	Object production
GB201310854D0 (en)	2013-07-31	Photoactive layer production process
PL3008122T3 (pl)	2018-01-31	Sposób wytwarzania spienionego granulatu
IL240748A0 (en)	2015-10-29	Methods for generating adenovirus
ZA201506050B (en)	2017-08-30	Vortioxetine manufacturing process
GB201414400D0 (en)	2014-10-01	Object production
IL241287A0 (en)	2015-11-30	Processes for the preparation of subfervir
GB2512711B (en)	2016-09-14	Graphene production method
IL242888B (en)	2018-08-30	New processes for the production of chemically-modified heparins
GB201322992D0 (en)	2014-02-12	New Process
GB201322303D0 (en)	2014-01-29	Production process
PT3017079T (pt)	2017-07-19	Processo de produção de camadas de tixsi1-xn
GB201317756D0 (en)	2013-11-20	New process
GB201313211D0 (en)	2013-09-04	New process
EP3041814B8 (en)	2017-12-13	Process for the production of dichlorohydrins
GB201306986D0 (en)	2013-05-29	Can production process
IL242373B (en)	2019-12-31	Biocatalytic process for the production of (r)-3-quinuclidinol
AU2013901412A0 (en)	2013-05-09	Production process
GB201303604D0 (en)	2013-04-10	Manufacturing process
GB201317272D0 (en)	2013-11-13	Object production
GB201314513D0 (en)	2013-09-25	Object production
GB201300852D0 (en)	2013-03-06	Object production
GB201321820D0 (en)	2014-01-22	Semiconducting layer production process
GB201303682D0 (en)	2013-04-17	Semiconducting layer production process